Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Ingenovis Health acquires healthcare staffing company

The tech-enabled platform for healthcare staffing agreed to acquire Orlando, Florida-based HealthCare Support.

Thumbnail

Healthcare lacks women in leadership

Healthcare is not a friendly industry for women in leadership, with women underrepresented on chairs and boards of directors.

Healthcare margins at risk from labor and supply chain challenges

Margin pressures among U.S. healthcare and pharmaceutical companies are at risk with renewed labor challenges and supply chain issues.

Thumbnail

Two private equity firms agree to purchase athenahealth for $17B

Bain Capital and Hellman & Friedman announced the move on Monday, acquiring the health tech company from Veritas Capital and Evergreen Coast Capital.

Thumbnail

Burnout among healthcare workers hits crisis level

Healthcare workers are more burned out than ever due to the impact of the COVID-19 pandemic––creating a new demand for workforce solutions.

Thumbnail

Kaufman Hall acquires Healthcare Real Estate Capital

Kaufman, Hall & Associates has acquired Healthcare Real Estate Capital, a national advisory firm focused on the healthcare and higher education real estate capital markets sectors.

 

Thumbnail

130-year-old Johnson & Johnson will split into two public companies

J&J's consumer business—responsible for Tylenol, Band-Aid and more household names—will separate from its pharmaceutical and medical device division.

Biden expected to choose cardiologist who served under Obama as next FDA commissioner

Robert Califf, MD, is a practicing cardiologist and professor of cardiology at the Duke University School of Medicine. 

Displaying 1609 - 1616 of 6647

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup